23 research outputs found
Body weight, metabolism and clock genes
Biological rhythms are present in the lives of almost all organisms ranging from plants to more evolved creatures. These oscillations allow the anticipation of many physiological and behavioral mechanisms thus enabling coordination of rhythms in a timely manner, adaption to environmental changes and more efficient organization of the cellular processes responsible for survival of both the individual and the species. Many components of energy homeostasis exhibit circadian rhythms, which are regulated by central (suprachiasmatic nucleus) and peripheral (located in other tissues) circadian clocks. Adipocyte plays an important role in the regulation of energy homeostasis, the signaling of satiety and cellular differentiation and proliferation. Also, the adipocyte circadian clock is probably involved in the control of many of these functions. Thus, circadian clocks are implicated in the control of energy balance, feeding behavior and consequently in the regulation of body weight. In this regard, alterations in clock genes and rhythms can interfere with the complex mechanism of metabolic and hormonal anticipation, contributing to multifactorial diseases such as obesity and diabetes. The aim of this review was to define circadian clocks by describing their functioning and role in the whole body and in adipocyte metabolism, as well as their influence on body weight control and the development of obesity
Is it time for oncologists to modify their laissez-faire attitude toward alternative/ complementary ‘drug therapy’?
Recommended from our members
Accuracy and Reproducibility of Myocardial Blood Flow Quantification by Single Photon Emission Computed Tomography Imaging in Patients With Known or Suspected Coronary Artery Disease
BackgroundSingle photon emission computed tomography (SPECT) has limited ability to identify multivessel and microvascular coronary artery disease. Gamma cameras with cadmium zinc telluride detectors allow the quantification of absolute myocardial blood flow (MBF) and myocardial flow reserve (MFR). However, evidence of its accuracy is limited, and of its reproducibility is lacking. We aimed to validate 99mTc-sestamibi SPECT MBF and MFR using standard and spline-fitted reconstruction algorithms compared with 13N-ammonia positron emission tomography in a cohort of patients with known or suspected coronary artery disease and to evaluate the reproducibility of this technique.MethodsAccuracy was assessed in 34 participants who underwent dynamic 99mTc-sestamibi SPECT and 13N-ammonia positron emission tomography and reproducibility in 14 participants who underwent 2 99mTc-sestamibi SPECT studies, all within 2 weeks. A rest/pharmacological stress single-day SPECT protocol was performed. SPECT images were reconstructed using a standard ordered subset expectation maximization (OSEM) algorithm with (N=21) and without (N=30) application of spline fitting. SPECT MBF was quantified using a net retention kinetic model' and MFR was derived as the stress/rest MBF ratio.ResultsSPECT global MBF with splines showed good correlation with 13N-ammonia positron emission tomography (r=0.81, P<0.001) and MFR estimates (r=0.74, P<0.001). Correlations were substantially weaker for standard reconstruction without splines (r=0.61, P<0.001 and r=0.34, P=0.07, for MBF and MFR, respectively). Reproducibility of global MBF estimates with splines in paired SPECT scans was good (r=0.77, P<0.001), while ordered subset expectation maximization without splines led to decreased MBF (r=0.68, P<0.001) and MFR correlations (r=0.33, P=0.3). There were no significant differences in MBF or MFR between the 2 reproducibility scans independently of the reconstruction algorithm (P>0.05 for all).ConclusionsMBF and MFR quantification using 99mTc-sestamibi cadmium zinc telluride SPECT with spatiotemporal spline fitting improved the correlation with 13N-ammonia positron emission tomography flow estimates and test/retest reproducibility. The use of splines may represent an important step toward the standardization of SPECT flow estimation
Quality of Online Pharmacies and Websites Selling Prescription Drugs: A Systematic Review
Background: Online pharmacies are companies that sell pharmaceutical preparations, including prescription-only drugs, on
the Internet. Very little is known about this phenomenon because many online pharmacies operate from remote countries, where
legal bases and business practices are largely inaccessible to international research.
Objective: The aim of the study was to perform an up-to-date and comprehensive review of the scientific literature focusing
on the broader picture of online pharmacies by scanning several scientific and institutional databases, with no publication time
limits.
Methods: We searched 4 electronic databases up to January 2011 and the gray literature on the Internet using the Google search
engine and its tool Google Scholar. We also investigated the official websites of institutional agencies (World Health Organization,
and US and European centers for disease control and drug regulation authorities). We focused specifically on online pharmacies
offering prescription-only drugs. We decided to analyze and report only articles with original data, in order to review all the
available data regarding online pharmacies and their usage.
Results: We selected 193 relevant articles: 76 articles with original data, and 117 articles without original data (editorials,
regulation articles, or the like) including 5 reviews. The articles with original data cover samples of online pharmacies in 47 cases,
online drug purchases in 13, consumer characteristics in 15, and case reports on adverse effects of online drugs in 12. The studies
show that random samples with no specific limits to prescription requirements found that at least some websites sold drugs without
a prescription and that an online questionnaire was a frequent tool to replace prescription. Data about geographical characteristics
show that this information can be concealed in many websites. The analysis of drug offer showed that online a consumer can get
virtually everything. Regarding quality of drugs, researchers very often found inappropriate packaging and labeling, whereas the
chemical composition usually was not as expected in a minority of the studies’ samples. Regarding consumers, the majority of
studies found that not more than 6% of the samples had bought drugs online.
Conclusions: Online pharmacies are an important phenomenon that is continuing to spread, despite partial regulation, due to
intrinsic difficulties linked to the impalpable and evanescent nature of the Web and its global dimension. To enhance the benefits
and minimize the risks of online pharmacies, a 2-level approach could be adopted. The first level should focus on policy, with
laws regulating the phenomenon at an international level. The second level needs to focus on the individual. This approach should
aim to increase health literacy, required for making appropriate health choices, recognizing risks and making the most of the
multitude of opportunities offered by the world of medicine 2.0